Insights Our Network Provides
We support high quality diagnostics, clinical trials, and real-world data across the U.S.
Insight Sharing
__________________
Through our participating groups, PVL can access an aggregate of over 3.2M pathology cases per year with primary source analysis and insights about pathology reports, genomic testing, digital images, practice patterns, etc. Our data has value for basic science, applied research and business analytics. Real-world pathology data at its origin provides unmatched opportunity to understand community pathology and is simply unavailable with the same authenticity elsewhere.
Practice Standardization
__________________
Standardization of best practices in diagnostics, including biomarker test ordering and reporting, is an important initiative for Pathology Ventures. We know our patients’ access to new therapies depends on the biomarker testing being performed in a timely and consistent fashion. We would welcome support as we develop standards for best ordering practices and pathology reporting. Contact us for more information.
Consulting Services
__________________
Through our network of participating groups, we can offer clients access to pathology expertise in every sub-specialty and in diverse geographies and demographics. Our network provides “one-stop shopping” enhancing its appeal to those customers seeking to better hear and understand the voice of the community pathologists.
Our Leadership
-
Samuel K. Caughron, MD
Director & President
Dr. Caughron has more than 20 years experience integrating advanced diagnostics into pathology practice and is a nationally recognized expert biomarker testing and the economic issues adjacent to molecular testing including in the community healthcare environment. Dr. Caughron has served on numerous national professional committees, boards and advisory panels including for AMP, CAP and industry and pharmaceutical partners. As the President of Pathology Ventures he leads the organization’s vision setting and operational strategy.
-
Vivek Khare, MD
Director & VP of Business Development
Dr. Vivek Khare has more than 25 years of experience building scalable, physician-led diagnostic platforms. His strategy merges clinical operations, infrastructure, and emerging technologies with physician-governed models to position for the next generation of diagnostics, data, and industry collaboration. As co-founder of Pathology Ventures and VP of Business Development, he is focused on building strategic relationships that enable high-quality operational and validation environments and analytics that translate directly into clinical and economic value for practicing physicians.
-
Eric Glassy, MD
Director & VP Scientific Affairs
Dr. Eric Glassy is nationally recognized with decades of leadership in advancing pathology reporting and digital pathology. His expertise centers on the design and implementation of structured reporting frameworks and synoptic reporting. He has played a key role in shaping national standards that improve consistency, quality, and usability of pathology data across diverse healthcare settings. At PVL, he helps drive strategies that leverage structured data, digital workflows, and emerging technologies to ensure pathology insights are precise, actionable, and directly aligned with clinical and economic value.